Cargando…
Repurposing Antimalarials to Tackle the COVID-19 Pandemic
Artemisinin-based combination therapies (ACTs) have demonstrated in vitro inhibition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Artemisinins have also shown anti-inflammatory effects, including inhibition of interleukin-6 (IL-6) that plays a key role in the development of sever...
Autores principales: | Krishna, Sanjeev, Augustin, Yolanda, Wang, Jigang, Xu, Chengchao, Staines, Henry M., Platteeuw, Hans, Kamarulzaman, Adeeba, Sall, Amadou, Kremsner, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572038/ https://www.ncbi.nlm.nih.gov/pubmed/33153922 http://dx.doi.org/10.1016/j.pt.2020.10.003 |
Ejemplares similares
-
Repurposing Antimalarials to Tackle the COVID-19 Pandemic: (Trends in Parasitology 37, 8–11; 2021)
por: Krishna, Sanjeev, et al.
Publicado: (2021) -
Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing
por: Augustin, Yolanda, et al.
Publicado: (2020) -
Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic
por: Wang, Jigang, et al.
Publicado: (2020) -
The wisdom of crowds and the repurposing of artesunate as an anticancer drug
por: Augustin, Yolanda, et al.
Publicado: (2015) -
How to tackle antimalarial resistance?
por: Leroy, Didier
Publicado: (2016)